Gene · 977
Papers2,195
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,195
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Small extracellular vesicles promote invadopodia activity in glioblastoma cells in a therapy-dependent manner. | Cell Oncol (Dordr) | 2023 | 37014551 | PubTator, text mining | PubMed |
| Prognostic value and multifaceted roles of tetraspanin CD9 in cancer. | Front Oncol | 2023 | 37007105 | PubTator, text mining | PubMed |
| Circulating Plasma Exosomal Proteins of Either SHIV-Infected Rhesus Macaque or HIV-Infected Patient Indicates a Link to Neuropathogenesis. | Viruses | 2023 | 36992502 | PubTator, text mining | PubMed |
| Machine learning integrations develop an antigen-presenting-cells and T-Cells-Infiltration derived LncRNA signature for improving clinical outcomes in hepatocellular carcinoma. | BMC Cancer | 2023 | 36978017 | PubTator, text mining | PubMed |
| The versatile roles of testrapanins in cancer from intracellular signaling to cell-cell communication: cell membrane proteins without ligands. | Cell Biosci | 2023 | 36941633 | PubTator, text mining | PubMed |
| Molecular genetic basis of epidermolysis bullosa. | Vavilovskii Zhurnal Genet Selektsii | 2023 | 36923479 | PubTator, text mining | PubMed |
| LOXL1 and LOXL4 are novel target genes of the Zn2+-bound form of ZEB1 and play a crucial role in the acceleration of invasive events in triple-negative breast cancer cells. | Front Oncol | 2023 | 36910659 | PubTator, text mining | PubMed |
| Platelet RNA enables accurate detection of ovarian cancer: an intercontinental, biomarker identification study. | Protein Cell | 2023 | 36905391 | PubTator, text mining | PubMed |
| Endostatin 33 Peptide Is a Deintegrin α6β1 Agent That Exerts Antitumor Activity by Inhibiting the PI3K-Akt Signaling Pathway in Prostate Cancer. | J Clin Med | 2023 | 36902648 | PubTator, text mining | PubMed |
| Proteomic profiling and ROC analysis identify CD151 and ELAVL1 as potential therapy response markers for the antiviral drug in resistant TNBC. | Life Sci | 2023 | 36889667 | PubTator, text mining | PubMed |
| The burden of diabetes on the soft tissue seal surrounding the dental implants. | Front Physiol | 2023 | 36875028 | PubTator, text mining | PubMed |
| Selection and Validation of Reference Genes for RT-qPCR Analysis of Gene Expression in Nicotiana benthamiana upon Single Infections by 11 Positive-Sense Single-Stranded RNA Viruses from Four Genera. | Plants (Basel) | 2023 | 36840204 | PubTator, text mining | PubMed |
| Therapeutic Implications of the Drug Resistance Conferred by Extracellular Vesicles Derived from Triple-Negative Breast Cancer Cells. | Int J Mol Sci | 2023 | 36835116 | PubTator, text mining | PubMed |
| Cell State Transitions and Phenotypic Heterogeneity in Luminal Breast Cancer Implicating MicroRNAs as Potential Regulators. | Int J Mol Sci | 2023 | 36834918 | PubTator, text mining | PubMed |
| Immunotherapeutic Approaches in Ovarian Cancer. | Curr Issues Mol Biol | 2023 | 36826026 | PubTator, text mining | PubMed |
| Single-cell pair-wise relationships untangled by composite embedding model. | iScience | 2023 | 36824286 | PubTator, text mining | PubMed |
| Mycobacterium abscessus alkyl hydroperoxide reductase C promotes cell invasion by binding to tetraspanin CD81. | iScience | 2023 | 36818301 | PubTator, text mining | PubMed |
| Total serum N-glycans associate with response to immune checkpoint inhibition therapy and survival in patients with advanced melanoma. | BMC Cancer | 2023 | 36805683 | PubTator, text mining | PubMed |
| FLI1 and FRA1 transcription factors drive the transcriptional regulatory networks characterizing muscle invasive bladder cancer. | Commun Biol | 2023 | 36805539 | PubTator, text mining | PubMed |
| Proteins Found in the Triple-Negative Breast Cancer Secretome and Their Therapeutic Potential. | Int J Mol Sci | 2023 | 36768435 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/977/papers?page=13